OPN and ACCP Hematology/Oncology PRN Journal Club - April 2026

April 16, 2026

- The OPN and the ACCP H/O PRN Journal Club is a monthly virtual (online) event. 

Overview

This presentation will provide an overview of the DESTINY-Breast09 clinical trial with a focus on study design, key efficacy results, safety outcomes, and clinical implications. Participants will gain insights into the advanced/metastatic HER2-positive breast cancer treatment landscape and the role of trastuzumab deruxtecan in combination with pertuzumab as a potential standard first-line therapy.

Identified Gap(s)

Oncology pharmacists lack regular, structured opportunities to engage with emerging literature and apply new evidence to clinical practice. The rapid pace of drug development, evolving treatment guidelines, and increasing complexity of oncology care demand ongoing education that is interactive and peer driven. The absence of oncology-specific journal clubs limits pharmacists’ ability to stay current, critically evaluate research, and contribute fully to multidisciplinary care—ultimately impacting patient outcomes.

Description of Current State

Oncology pharmacists are increasingly stepping into high-value, patient-focused roles due to the growing complexity of cancer care and shortages of oncologists and nurses. With over 50 new cancer drugs approved in 2024 alone, the need for pharmacists to stay current with treatment advances is critical.1 However, educational gaps persist, as pharmacists often lack access to oncology-focused continuing education. As drug experts on the care team, they must be equipped to manage complex therapies and fill care gaps—particularly in areas like pregnancy-associated cancer and supportive care.

Description of desired/achievable state

Oncology pharmacists will have access to a virtual, accredited journal club designed to support continuous learning and clinical application of emerging evidence. This interactive platform will foster peer-to-peer discussion, enhance critical literature appraisal skills, and empower pharmacists to deliver evidence-based care in complex scenarios, ultimately strengthening their role within the oncology care team.

Upon completion of this journal club, you will:

  1. Discuss potential sources of bias, limitations, and strengths of each clinical study
  2. Assess the validity, relevance, and applicability of the latest clinical research studies

Target Audience

This activity is intended for oncology pharmacists, pharmacy techs, and pharmacy residents who are involved in the treatment of cancer patients.

Presented By

                         

Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Live activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens: 
03/30/2026
Course expires: 
05/17/2026
Event starts: 
04/16/2026 - 11:55am PDT
Event ends: 
04/16/2026 - 12:35pm PDT
Cost:
$0.00
Rating: 
0

Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.

All Times Listed are for the Eastern Standard Time Zone

 Thursday April 16, 2026

3:00pmWelcome and Introduction
» Olivia White, PharmD, BCOP
3:05pmOPN and ACCP Hematology/Oncology PRN Journal Club - April 2026 
» Minh Nguyen
3:35pm

Breakout Room and Closing Comments
» Olivia White, PharmD, BCOP

Online Livecast
United States

Faculty


Olivia White, PharmD, BCOP (Moderator)

Hematology/Oncology Pharmacy Specialist
University of Texas Southwestern Medical Center
Dallas, TX

Dr. Olivia White is a Hematology/Oncology Pharmacy Specialist at the University of Texas Southwestern Medical Center. She completed her pharmacy school at University of Kentucky in 2021, followed by a 2-year residency program specializing in Hematology and Oncology at Duke University Hospital. Her areas of interest include malignant hematology management, cardio-oncology, pharmacoequity, and expanding the role of the pharmacist in hematology/oncology practice.


Minh Nguyenn (Speaker)

PharmD Candidate 2027
The University of Texas at Austin
Austin, TX

Minh Nguyen is a third-year pharmacy student at The University of Texas at Austin College of Pharmacy. She is pursuing the Research Honors and the Inpatient Distinction Pathway, reflecting her strong interest in clinical research and pharmacy practice. Prior to entering pharmacy school, she earned a Bachelor in Biochemistry and Economics from The University of Texas at Austin, providing her with a strong scientific background alongside an understanding of economic factors that affect patient care.

Minh is actively involved in leadership across several pharmacy organizations. She currently serves as President of the Student College of Clinical Pharmacy (SCCP) after previously serving as Vice President. Minh also holds leadership roles as Drug Updates Chair for the Network for Collaborative Oncology Development & Advancement (NCODA), Alumni Relations Chair for the Rho Chi Pharmacy Honor Society, and Director of Professional Programming for the Industry Pharmacists Organization (IPhO). She was also active in community outreach through the Student National Pharmaceutical Association (SNPhA) as National Power to End Stroke Subcommittee Chair.

Minh previously worked as an outpatient pharmacist intern at Ascension Seton Medical Center Austin, where she gained hands-on experience in patient care and medication management. Her professional interests include oncology and cardiology, with a focus on improving patient care and medication access.
 


Program Planners


Shawn Griffin

Oncology Pharmacist/Assistant Clinical Professor
University of California, Irvine 
Irvine, California

Shawn Griffin is a Board Certified Oncology Pharmacist and Health Sciences Assistant Clinical Professor in the Department of Clinical Pharmacy Practice at the University of California, Irvine (UCI) School of Pharmacy & Pharmaceutical Sciences. He practices within the Hematopoietic Stem Cell Transplantation and Cellular Therapy Program at the Chao Family Comprehensive Cancer Center. Prior to joining UCI, Griffin worked as a Hematology/Stem Cell Transplant pharmacist at Indiana University Health for five years. He received PharmD from the UNC Eshelman School of Pharmacy and completed a PGY1 Pharmacy and PGY2 Oncology Pharmacy Residency at the University of Florida Health Shands Hospital.


Disclosures


Horizon CME requires all planners, faculty, and other contributors to disclose any financial relationships with an ACCME defined ineligible company within the past 24 months and Horizon CME has resolved any conflicts prior to this educational activity.
Planners

*Horizon CME has mitigated and resolved all relevant financial relationships

Those others involved in the planning of this activity disclosed no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Other Contributors

Other Contributors

All other non-faculty contributors and others involved in the planning, development and editing/review of the content disclosed no relevant financial relationships with any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients.

Available Credit

  • 0.50 AMA PRA Category 1 Credit

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Live activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above


Supported Phones & Tablets:

Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above

How to obtain credit for attendance (eligibility requirement and process for obtaining certificate)
To receive documentation of credit, participants must:

  1. Login to the educational portal

  2. Attend the educational activity

  3. Complete the online evaluation form. The last day to access the evaluation is May 17, 2026 at 11:59pm PST* 

  4. Attest to the number of hours in attendance in order to generate your certificate 

*Requests from learners to claim credit after the evaluation closes will not be granted